Mundipharma announced on Thursday that it has entered into an agreement with Janssen Pharmaceuticals, Inc to acquire rights to the extended release cancer pain treatment Tapenta tablet in 25mg, 50mg, 100mg doses in Japan. The generic name is Tapentadol Hydrochloride.